Abstract
The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.
| Original language | English (US) |
|---|---|
| Title of host publication | Ethical Foundations of Palliative Care for Alzheimer Disease |
| Publisher | The Johns Hopkins University Press |
| Pages | 330-342 |
| Number of pages | 13 |
| ISBN (Print) | 0801878705, 9780801898396 |
| State | Published - Dec 1 2010 |
All Science Journal Classification (ASJC) codes
- Arts and Humanities(all)
Fingerprint Dive into the research topics of 'Drugs and dementia: Pharmacotherapy and decision making by primary caregivers'. Together they form a unique fingerprint.
Cite this
Haddad, A. M. (2010). Drugs and dementia: Pharmacotherapy and decision making by primary caregivers. In Ethical Foundations of Palliative Care for Alzheimer Disease (pp. 330-342). The Johns Hopkins University Press.